Geode Capital Management LLC Has $3.35 Million Stock Holdings in Senseonics Holdings, Inc. (NYSE:SENS)

Geode Capital Management LLC grew its position in Senseonics Holdings, Inc. (NYSE:SENS - Free Report) by 9.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,405,100 shares of the company's stock after purchasing an additional 566,704 shares during the period. Geode Capital Management LLC owned approximately 1.08% of Senseonics worth $3,354,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of SENS. Raymond James Financial Inc. bought a new stake in shares of Senseonics in the fourth quarter worth $26,000. HighTower Advisors LLC bought a new stake in Senseonics during the 4th quarter worth about $32,000. Ridgecrest Wealth Partners LLC acquired a new position in shares of Senseonics during the 4th quarter worth about $60,000. Charles Schwab Investment Management Inc. boosted its position in Senseonics by 9.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock valued at $1,748,000 after purchasing an additional 274,842 shares during the last quarter. Finally, Virtu Financial LLC bought a new position in Senseonics in the fourth quarter valued at approximately $148,000. Institutional investors and hedge funds own 12.36% of the company's stock.

Senseonics Stock Performance

Shares of Senseonics stock traded up $0.03 on Friday, hitting $0.76. The stock had a trading volume of 995,781 shares, compared to its average volume of 6,298,692. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The stock has a market cap of $494.59 million, a price-to-earnings ratio of -5.82 and a beta of 0.84. The business's 50 day moving average is $0.67 and its two-hundred day moving average is $0.61. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $1.40.

Senseonics (NYSE:SENS - Get Free Report) last issued its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period in the prior year, the firm earned ($0.07) earnings per share. Analysts forecast that Senseonics Holdings, Inc. will post -0.14 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on the stock. HC Wainwright reiterated a "buy" rating and issued a $2.00 price target on shares of Senseonics in a research note on Wednesday, March 5th. Mizuho initiated coverage on shares of Senseonics in a research note on Thursday, April 10th. They issued an "outperform" rating and a $2.00 target price for the company.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.